-
[Latest] Global Liver Cancer Market Size/Share Worth USD 16.3 Billion by 2033 at a 14.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
03 Apr 2024 16:30 GMT
… Sirtex Medical Limited
Sorafenib (Nexavar)
Taiho Pharmaceutical Co. Ltd … By Type of Cancer (Breast Cancer, Lung Cancer, Brain … Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer … By Type of Cancer (Breast Cancer, Lung Cancer, Prostate Cancer …
-
Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
18 Mar 2024 08:12 GMT
… is sorafenib, also known as Nexavar or sorafenib tosylate, which has … the growth and metastasis of breast cancer in mice. Phytother Res. 2021 … or trastuzumab in patients with breast cancer. Eur Heart J. 2022;43 …
-
An Overview of Traditional Chinese Medicine in the Treatment After Radical Resection of Hepatocellular Carcinoma
18 Dec 2023 04:15 GMT
… , cervical cancer, nasopharyngeal carcinoma and breast cancer.79 TCM plays a more … the multi-kinase inhibitor sorafenib (Nexavar) is an oral drug and …
-
Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects
17 Nov 2023 09:22 GMT
… in advanced bone metastases from breast cancer to differentiate into DC-OCs … . Examples of these drugs include Nexavar and Votrient. When considering the … osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone …
-
Regulatory tracker: Phathom finally nears Voquezna's commercial debut after new FDA nod
17 May 2023 16:11 GMT
… HR+/HER2- metastatic breast cancer.
Specifically, the drug … Bayer’s old standard Nexavar. Patients who took … , HER2-negative metastatic breast cancer whose disease has progressed … locally advanced or metastatic breast cancer after recurrence or progression …
-
Global Kidney Cancer Drugs Market Projected Growth Until 2030
15 Nov 2022 14:05 GMT
… Carcinoma (UCC)
• By Product – Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus … The Business Research Company:
Breast Cancer Drugs Global Market Report 2022 … .com/report/breast-cancer-drugs-global-market-report
Cancer …
-
Desperate writ petitions of dying patients
29 Sep 2022 04:05 GMT
… ribociclib to treat her metastatic breast cancer.
In her writ petition filed … number of women succumb to breast cancer because of their inability to … of the drug (brand name Nexavar) from a whopping Rs 2 …
-
Insights Into The Global Kidney Cancer Drugs Market 2022-2031 Forecast Period
22 Sep 2022 19:15 GMT
… Sarcoma, Renal Lymphoma)
• By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor ( … The Business Research Company:
Breast Cancer Drugs Global Market Report 2022 … .com/report/breast-cancer-drugs-global-market-report
Cancer …
-
Bayer Demonstrates Commitment to Advancing Oncology by Showcasing New Data From Innovative Science at ESMO Congress 2022
30 Aug 2022 12:50 GMT
… on Other Drugs – NUBEQA inhibits breast cancer resistance protein (BCRP) transporter. Concomitant … have been previously treated with Nexavar® (sorafenib). In the United States …